<p>隨着全球市場在複雜的經濟環境中航行，亞洲股票憑藉其多樣化的機會繼續吸引投資者的關注。便士股票通常代表較小或較新的公司，仍然是尋求低價位增長的投資者的一個引人注目的領域。儘管這個術語有些過時，但當這些股票有強大的財務支持和明確的增長潛力時，仍然可以提供顯著的價值。</p>
<h3>亞洲十大便士股票</h3>
<table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名稱</strong></td>
<td><strong>股價</strong></td>
<td><strong>市值</strong></td>
<td><strong>收益與風險</strong></td>
</tr>
<tr>
<td>Lever Style (SEHK:1346)</td>
<td>HK$1.45</td>
<td>HK$896.85M</td>
<td>✅ 4 ⚠️ 1 查看分析 </td>
</tr>
<tr>
<td>Asia Medical and Agricultural Laboratory and Research Center (SET:AMARC)</td>
<td>THB2.50</td>
<td>THB1.05B</td>
<td>✅ 3 ⚠️ 3 查看分析 </td>
</tr>
<tr>
<td>TK Group (Holdings) (SEHK:2283)</td>
<td>HK$2.56</td>
<td>HK$2.12B</td>
<td>✅ 4 ⚠️ 1 查看分析 </td>
</tr>
<tr>
<td>Panjawattana Plastic (SET:PJW)</td>
<td>THB2.04</td>
<td>THB1.18B</td>
<td>✅ 4 ⚠️ 2 查看分析 </td>
</tr>
<tr>
<td>Atlantic Navigation Holdings (Singapore) (Catalist:5UL)</td>
<td>SGD0.105</td>
<td>SGD54.97M</td>
<td>✅ 2 ⚠️ 3 查看分析 </td>
</tr>
<tr>
<td>Yangzijiang Shipbuilding (Holdings) (SGX:BS6)</td>
<td>SGD3.64</td>
<td>SGD14.33B</td>
<td>✅ 5 ⚠️ 1 查看分析 </td>
</tr>
<tr>
<td>NagaCorp (SEHK:3918)</td>
<td>HK$4.64</td>
<td>HK$20.52B</td>
<td>✅ 5 ⚠️ 1 查看分析 </td>
</tr>
<tr>
<td>Livestock Improvement (NZSE:LIC)</td>
<td>NZ$1.00</td>
<td>NZ$137.01M</td>
<td>✅ 2 ⚠️ 5 查看分析 </td>
</tr>
<tr>
<td>Bosideng International Holdings (SEHK:3998)</td>
<td>HK$4.40</td>
<td>HK$51.08B</td>
<td>✅ 4 ⚠️ 2 查看分析 </td>
</tr>
<tr>
<td>Scott Technology (NZSE:SCT)</td>
<td>NZ$2.82</td>
<td>NZ$235.47M</td>
<td>✅ 4 ⚠️ 1 查看分析 </td>
</tr>
</tbody>
</table>
<p>點擊這裏查看我們亞洲便士股票篩選器的 958 只股票的完整列表。</p>
<p>下面我們展示了一些經過篩選的股票。</p>
<h2>Ley Choon Group Holdings (Catalist:Q0X)</h2>
<p><strong>Simply Wall St 財務健康評級：</strong> ★★★★★★</p>
<p><strong>概述：</strong> Ley Choon Group Holdings Limited 是一家投資控股公司，提供新加坡和斯里蘭卡的地下公用設施基礎設施建設服務，市值為 SGD150.58 百萬。</p>
<p><strong>運營：</strong> 公司的收入主要來自其管道和道路部門，貢獻 SGD176.34 百萬，以及其建築材料部門，增加 SGD30.97 百萬。</p>
<p><strong>市值：</strong> SGD150.58M</p>
<p>Ley Choon Group Holdings Limited 市值為 SGD150.58 百萬，過去一年保持無債務並避免股東稀釋，展現出穩定性。公司從其管道和道路部門（SGD176.34 百萬）和建築材料部門（SGD30.97 百萬）產生顯著收入，儘管最近的收益顯示截至 2025 年 9 月的半年淨收入略微下降至 SGD6.08 百萬。其經驗豐富的管理團隊與缺乏經驗的董事會形成對比，而短期資產足以覆蓋短期和長期負債，支持在波動市場中的財務韌性。</p>
<ul>
<li>點擊這裏發現 Ley Choon Group Holdings 的細微差別，查看我們的詳細分析財務健康報告。</li>
<li>查看我們的歷史業績報告，以獲取 Ley Choon Group Holdings 的業績記錄。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/7f961e36-871c-4c6c-8b6f-aae9f2450ada/chart/debt-equity-history-analysis?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/7f961e36-871c-4c6c-8b6f-aae9f2450ada/chart/debt-equity-history-analysis"/></p>
<p>Catalist:Q0X 債務與股本歷史及分析截至 2026 年 1 月</p>
<h2>Sipai Health Technology (SEHK:314)</h2>
<p><strong>Simply Wall St 財務健康評級：</strong> ★★★★★☆</p>
<p><strong>概述：</strong> Sipai Health Technology Co., Ltd.是一家在中華人民共和國運營的醫療技術和健康管理公司，市值為 HK$2.07 億。</p>
<p><strong>運營：</strong> Sipai Health Technology 的收入主要來自其專業藥房業務，貢獻 CN¥2.83 億，其次是醫生研究輔助業務，貢獻 CN¥425.36 百萬，以及健康保險服務業務，貢獻 CN¥166.43 百萬。</p>
<p><strong>市值：</strong> HK$2.07B</p>
<p>Sipai Health Technology 市值為 HK$2.07 億，主要通過其專業藥房業務產生 CN¥2.83 億的收入。儘管目前處於虧損狀態，並預計在未來三年內不會實現盈利，但公司在過去五年中將損失減少了 53.1%，並預測年收入增長率為 15.27%。其交易價格低於估計公允價值的 70.9%，並且在當前自由現金流的基礎上保持無債務，現金流足夠支撐超過三年的運營，同時其經驗豐富的管理團隊在最近的董事會變動中支持戰略穩定。</p>
<ul>
<li>通過閲讀我們的資產負債表健康報告，深入瞭解 Sipai Health Technology 的表現。</li>
<li>通過檢查我們的增長報告，瞭解 Sipai Health Technology 的盈利前景。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/89a248de-4029-4a6c-8722-091007f2d55d/chart/financial-position-analysis?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/89a248de-4029-4a6c-8722-091007f2d55d/chart/financial-position-analysis"/></p>
<p>SEHK:314 財務狀況分析截至 2026 年 1 月</p>
<h2>Adicon Holdings (SEHK:9860)</h2>
<p><strong>Simply Wall St 財務健康評級：</strong> ★★★★☆☆</p>
<p><strong>概述：</strong> Adicon Holdings Limited 是一家投資控股公司，提供在中華人民共和國的醫療檢測服務，市值為 HK$3.20 億。</p>
<p><strong>運營：</strong> 公司的收入主要來自其醫療設施與服務部門，總計 CN¥2.72 億。</p>
<p><strong>市值：</strong> HK$3.2B</p>
<p>艾迪康控股的市值為 32 億港元，其 27.2 億人民幣的收入來自中國的醫療服務。儘管在過去五年中處於虧損狀態並經歷了損失增加，但其每週波動率保持在 6% 的穩定水平，淨負債與股本比率為 32.5%，表現令人滿意。公司的短期資產（29 億人民幣）超過了短期負債（19 億人民幣）和長期負債（8.658 億人民幣）。儘管朱喬納森先生最近辭去了董事會職務，艾迪康的管理團隊仍然經驗豐富，平均任期為 4.2 年，支持未來潛在的戰略舉措。</p>
<ul>
<li>通過我們的綜合資產負債表健康報告，深入瞭解艾迪康控股的複雜性。</li>
<li>查看我們的增長表現報告，以獲取關於艾迪康控股未來的見解。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/4a50de19-77c6-4173-aab9-81d2af195aa5/chart/revenue-and-expenses-breakdown?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/4a50de19-77c6-4173-aab9-81d2af195aa5/chart/revenue-and-expenses-breakdown"/></p>
<p>SEHK:9860 截至 2026 年 1 月的收入與支出明細</p>
<h2>將想法轉化為行動</h2>
<ul>
<li>深入瞭解我們識別的所有 958 只亞洲便士股票。</li>
<li>準備進入其他投資風格嗎？這項技術可能取代計算機：發現 29 只股票正在努力使量子計算成為現實。</li>
</ul>
<p><em>本文由 Simply Wall St 撰寫，內容具有一般性。<strong>我們提供基於歷史數據和分析師預測的評論，採用無偏見的方法，我們的文章並不構成財務建議。</strong> 這並不構成買入或賣出任何股票的推薦，也未考慮您的目標或財務狀況。我們的目標是為您提供以基本數據驅動的長期分析。請注意，我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中沒有持倉。</em></p>

立堾集團控股

艾迪康控股

思派健康

<p>亞洲股票，特別是便士股票，因其在較低價格點的增長潛力而吸引了投資者的關注。值得注意的選擇包括立堾集團控股、思派健康科技和艾迪康控股，它們各自具有獨特的市場定位和財務健康評級。立堾集團市值為 1.5058 億新加坡元，顯示出穩定性，沒有債務，但淨收入略有下降。思派健康科技的估值為 20.7 億港元，雖然尚未盈利，但預計將實現顯著的收入增長。艾迪康控股市值為 32 億港元，雖然也面臨虧損，但保持了穩健的財務狀況</p>

<p>As global markets navigate a complex economic landscape, Asian equities continue to capture investor attention with their diverse opportunities. Penny stocks, often representing smaller or newer companies, remain an intriguing segment for investors seeking growth at lower price points. Despite the term's vintage connotations, these stocks can offer significant value when backed by strong financials and clear growth potential.</p>
<div class="lb-trans"><p>隨着全球市場在複雜的經濟環境中航行，亞洲股票憑藉其多樣化的機會繼續吸引投資者的關注。便士股票通常代表較小或較新的公司，仍然是尋求低價位增長的投資者的一個引人注目的領域。儘管這個術語有些過時，但當這些股票有強大的財務支持和明確的增長潛力時，仍然可以提供顯著的價值。</p>
</div><h3>Top 10 Penny Stocks In Asia</h3>
<div class="lb-trans"><h3>亞洲十大便士股票</h3>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Name</strong></td>
<td><strong>Share Price</strong></td>
<td><strong>Market Cap</strong></td>
<td><strong>Rewards &amp; Risks</strong></td>
</tr>
<tr>
<td>Lever Style (SEHK:1346)</td>
<td>HK$1.45</td>
<td>HK$896.85M</td>
<td>✅ 4 ⚠️ 1 View Analysis &gt;</td>
</tr>
<tr>
<td>Asia Medical and Agricultural Laboratory and Research Center (SET:AMARC)</td>
<td>THB2.50</td>
<td>THB1.05B</td>
<td>✅ 3 ⚠️ 3 View Analysis &gt;</td>
</tr>
<tr>
<td>TK Group (Holdings) (SEHK:2283)</td>
<td>HK$2.56</td>
<td>HK$2.12B</td>
<td>✅ 4 ⚠️ 1 View Analysis &gt;</td>
</tr>
<tr>
<td>Panjawattana Plastic (SET:PJW)</td>
<td>THB2.04</td>
<td>THB1.18B</td>
<td>✅ 4 ⚠️ 2 View Analysis &gt;</td>
</tr>
<tr>
<td>Atlantic Navigation Holdings (Singapore) (Catalist:5UL)</td>
<td>SGD0.105</td>
<td>SGD54.97M</td>
<td>✅ 2 ⚠️ 3 View Analysis &gt;</td>
</tr>
<tr>
<td>Yangzijiang Shipbuilding (Holdings) (SGX:BS6)</td>
<td>SGD3.64</td>
<td>SGD14.33B</td>
<td>✅ 5 ⚠️ 1 View Analysis &gt;</td>
</tr>
<tr>
<td>NagaCorp (SEHK:3918)</td>
<td>HK$4.64</td>
<td>HK$20.52B</td>
<td>✅ 5 ⚠️ 1 View Analysis &gt;</td>
</tr>
<tr>
<td>Livestock Improvement (NZSE:LIC)</td>
<td>NZ$1.00</td>
<td>NZ$137.01M</td>
<td>✅ 2 ⚠️ 5 View Analysis &gt;</td>
</tr>
<tr>
<td>Bosideng International Holdings (SEHK:3998)</td>
<td>HK$4.40</td>
<td>HK$51.08B</td>
<td>✅ 4 ⚠️ 2 View Analysis &gt;</td>
</tr>
<tr>
<td>Scott Technology (NZSE:SCT)</td>
<td>NZ$2.82</td>
<td>NZ$235.47M</td>
<td>✅ 4 ⚠️ 1 View Analysis &gt;</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名稱</strong></td>
<td><strong>股價</strong></td>
<td><strong>市值</strong></td>
<td><strong>收益與風險</strong></td>
</tr>
<tr>
<td>Lever Style (SEHK:1346)</td>
<td>HK$1.45</td>
<td>HK$896.85M</td>
<td>✅ 4 ⚠️ 1 查看分析 </td>
</tr>
<tr>
<td>Asia Medical and Agricultural Laboratory and Research Center (SET:AMARC)</td>
<td>THB2.50</td>
<td>THB1.05B</td>
<td>✅ 3 ⚠️ 3 查看分析 </td>
</tr>
<tr>
<td>TK Group (Holdings) (SEHK:2283)</td>
<td>HK$2.56</td>
<td>HK$2.12B</td>
<td>✅ 4 ⚠️ 1 查看分析 </td>
</tr>
<tr>
<td>Panjawattana Plastic (SET:PJW)</td>
<td>THB2.04</td>
<td>THB1.18B</td>
<td>✅ 4 ⚠️ 2 查看分析 </td>
</tr>
<tr>
<td>Atlantic Navigation Holdings (Singapore) (Catalist:5UL)</td>
<td>SGD0.105</td>
<td>SGD54.97M</td>
<td>✅ 2 ⚠️ 3 查看分析 </td>
</tr>
<tr>
<td>Yangzijiang Shipbuilding (Holdings) (SGX:BS6)</td>
<td>SGD3.64</td>
<td>SGD14.33B</td>
<td>✅ 5 ⚠️ 1 查看分析 </td>
</tr>
<tr>
<td>NagaCorp (SEHK:3918)</td>
<td>HK$4.64</td>
<td>HK$20.52B</td>
<td>✅ 5 ⚠️ 1 查看分析 </td>
</tr>
<tr>
<td>Livestock Improvement (NZSE:LIC)</td>
<td>NZ$1.00</td>
<td>NZ$137.01M</td>
<td>✅ 2 ⚠️ 5 查看分析 </td>
</tr>
<tr>
<td>Bosideng International Holdings (SEHK:3998)</td>
<td>HK$4.40</td>
<td>HK$51.08B</td>
<td>✅ 4 ⚠️ 2 查看分析 </td>
</tr>
<tr>
<td>Scott Technology (NZSE:SCT)</td>
<td>NZ$2.82</td>
<td>NZ$235.47M</td>
<td>✅ 4 ⚠️ 1 查看分析 </td>
</tr>
</tbody>
</table>
</div><p>Click here to see the full list of 958 stocks from our Asian Penny Stocks screener.</p>
<div class="lb-trans"><p>點擊這裏查看我們亞洲便士股票篩選器的 958 只股票的完整列表。</p>
</div><p>Underneath we present a selection of stocks filtered out by our screen.</p>
<div class="lb-trans"><p>下面我們展示了一些經過篩選的股票。</p>
</div><h2>Ley Choon Group Holdings (Catalist:Q0X)</h2>
<div class="lb-trans"><h2>Ley Choon Group Holdings (Catalist:Q0X)</h2>
</div><p><strong>Simply Wall St Financial Health Rating:</strong> ★★★★★★</p>
<div class="lb-trans"><p><strong>Simply Wall St 財務健康評級：</strong> ★★★★★★</p>
</div><p><strong>Overview:</strong> Ley Choon Group Holdings Limited is an investment holding company that offers underground utilities infrastructure construction services in Singapore and Sri Lanka, with a market capitalization of SGD150.58 million.</p>
<div class="lb-trans"><p><strong>概述：</strong> Ley Choon Group Holdings Limited 是一家投資控股公司，提供新加坡和斯里蘭卡的地下公用設施基礎設施建設服務，市值為 SGD150.58 百萬。</p>
</div><p><strong>Operations:</strong> The company's revenue is primarily generated from its Pipes and Roads segment, contributing SGD176.34 million, and its Construction Materials segment, which adds SGD30.97 million.</p>
<div class="lb-trans"><p><strong>運營：</strong> 公司的收入主要來自其管道和道路部門，貢獻 SGD176.34 百萬，以及其建築材料部門，增加 SGD30.97 百萬。</p>
</div><p><strong>Market Cap:</strong> SGD150.58M</p>
<div class="lb-trans"><p><strong>市值：</strong> SGD150.58M</p>
</div><p>Ley Choon Group Holdings Limited, with a market capitalization of SGD150.58 million, has demonstrated stability by maintaining no debt and avoiding shareholder dilution over the past year. The company generates significant revenue from its Pipes and Roads segment (SGD176.34 million) and Construction Materials segment (SGD30.97 million), though recent earnings showed a slight decline in net income to SGD6.08 million for the half-year ended September 2025 compared to the previous year. Its experienced management team contrasts with an inexperienced board, while short-term assets comfortably cover both short- and long-term liabilities, supporting financial resilience in volatile markets.</p>
<div class="lb-trans"><p>Ley Choon Group Holdings Limited 市值為 SGD150.58 百萬，過去一年保持無債務並避免股東稀釋，展現出穩定性。公司從其管道和道路部門（SGD176.34 百萬）和建築材料部門（SGD30.97 百萬）產生顯著收入，儘管最近的收益顯示截至 2025 年 9 月的半年淨收入略微下降至 SGD6.08 百萬。其經驗豐富的管理團隊與缺乏經驗的董事會形成對比，而短期資產足以覆蓋短期和長期負債，支持在波動市場中的財務韌性。</p>
</div><ul>
<li>Click here to discover the nuances of Ley Choon Group Holdings with our detailed analytical financial health report.</li>
<li>Review our historical performance report to gain insights into Ley Choon Group Holdings' track record.</li>
</ul>
<div class="lb-trans"><ul>
<li>點擊這裏發現 Ley Choon Group Holdings 的細微差別，查看我們的詳細分析財務健康報告。</li>
<li>查看我們的歷史業績報告，以獲取 Ley Choon Group Holdings 的業績記錄。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/7f961e36-871c-4c6c-8b6f-aae9f2450ada/chart/debt-equity-history-analysis" alt="" original-src="https://images.simplywall.st/company/7f961e36-871c-4c6c-8b6f-aae9f2450ada/chart/debt-equity-history-analysis"/></p>
<p>Catalist:Q0X Debt to Equity History and Analysis as at Jan 2026</p>
<div class="lb-trans"><p>Catalist:Q0X 債務與股本歷史及分析截至 2026 年 1 月</p>
</div><h2>Sipai Health Technology (SEHK:314)</h2>
<div class="lb-trans"><h2>Sipai Health Technology (SEHK:314)</h2>
</div><p><strong>Simply Wall St Financial Health Rating:</strong> ★★★★★☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 財務健康評級：</strong> ★★★★★☆</p>
</div><p><strong>Overview:</strong> Sipai Health Technology Co., Ltd. is a medical technology and health management company operating in the People's Republic of China, with a market cap of HK$2.07 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> Sipai Health Technology Co., Ltd.是一家在中華人民共和國運營的醫療技術和健康管理公司，市值為 HK$2.07 億。</p>
</div><p><strong>Operations:</strong> Sipai Health Technology generates revenue primarily from its Specialty Pharmacy Business, which accounts for CN¥2.83 billion, followed by the Physician Research Assistance Business at CN¥425.36 million and the Health Insurance Services Business at CN¥166.43 million.</p>
<div class="lb-trans"><p><strong>運營：</strong> Sipai Health Technology 的收入主要來自其專業藥房業務，貢獻 CN¥2.83 億，其次是醫生研究輔助業務，貢獻 CN¥425.36 百萬，以及健康保險服務業務，貢獻 CN¥166.43 百萬。</p>
</div><p><strong>Market Cap:</strong> HK$2.07B</p>
<div class="lb-trans"><p><strong>市值：</strong> HK$2.07B</p>
</div><p>Sipai Health Technology, with a market cap of HK$2.07 billion, operates primarily through its Specialty Pharmacy Business generating CN¥2.83 billion in revenue. Despite being unprofitable and not expected to achieve profitability in the next three years, the company has reduced losses by 53.1% annually over five years and forecasts a 15.27% annual revenue growth rate. It trades at 70.9% below estimated fair value and remains debt-free with sufficient cash runway for over three years based on current free cash flow, while its experienced management team supports strategic stability amidst recent board changes.</p>
<div class="lb-trans"><p>Sipai Health Technology 市值為 HK$2.07 億，主要通過其專業藥房業務產生 CN¥2.83 億的收入。儘管目前處於虧損狀態，並預計在未來三年內不會實現盈利，但公司在過去五年中將損失減少了 53.1%，並預測年收入增長率為 15.27%。其交易價格低於估計公允價值的 70.9%，並且在當前自由現金流的基礎上保持無債務，現金流足夠支撐超過三年的運營，同時其經驗豐富的管理團隊在最近的董事會變動中支持戰略穩定。</p>
</div><ul>
<li>Get an in-depth perspective on Sipai Health Technology's performance by reading our balance sheet health report here.</li>
<li>Understand Sipai Health Technology's earnings outlook by examining our growth report.</li>
</ul>
<div class="lb-trans"><ul>
<li>通過閲讀我們的資產負債表健康報告，深入瞭解 Sipai Health Technology 的表現。</li>
<li>通過檢查我們的增長報告，瞭解 Sipai Health Technology 的盈利前景。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/89a248de-4029-4a6c-8722-091007f2d55d/chart/financial-position-analysis" alt="" original-src="https://images.simplywall.st/company/89a248de-4029-4a6c-8722-091007f2d55d/chart/financial-position-analysis"/></p>
<p>SEHK:314 Financial Position Analysis as at Jan 2026</p>
<div class="lb-trans"><p>SEHK:314 財務狀況分析截至 2026 年 1 月</p>
</div><h2>Adicon Holdings (SEHK:9860)</h2>
<div class="lb-trans"><h2>Adicon Holdings (SEHK:9860)</h2>
</div><p><strong>Simply Wall St Financial Health Rating:</strong> ★★★★☆☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 財務健康評級：</strong> ★★★★☆☆</p>
</div><p><strong>Overview:</strong> Adicon Holdings Limited is an investment holding company that offers medical testing services in the People’s Republic of China, with a market cap of HK$3.20 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> Adicon Holdings Limited 是一家投資控股公司，提供在中華人民共和國的醫療檢測服務，市值為 HK$3.20 億。</p>
</div><p><strong>Operations:</strong> The company's revenue is primarily derived from its Healthcare Facilities &amp; Services segment, totaling CN¥2.72 billion.</p>
<div class="lb-trans"><p><strong>運營：</strong> 公司的收入主要來自其醫療設施與服務部門，總計 CN¥2.72 億。</p>
</div><p><strong>Market Cap:</strong> HK$3.2B</p>
<div class="lb-trans"><p><strong>市值：</strong> HK$3.2B</p>
</div><p>Adicon Holdings, with a market cap of HK$3.20 billion, derives its CN¥2.72 billion revenue from healthcare services in China. Despite being unprofitable and experiencing increased losses over the past five years, it maintains stable weekly volatility at 6% and has a satisfactory net debt to equity ratio of 32.5%. The company’s short-term assets (CN¥2.9 billion) exceed both short-term liabilities (CN¥1.9 billion) and long-term liabilities (CN¥865.8 million). Although Mr. Zhu Jonathan resigned from the board recently, Adicon's management team remains experienced with an average tenure of 4.2 years, supporting potential strategic initiatives moving forward.</p>
<div class="lb-trans"><p>艾迪康控股的市值為 32 億港元，其 27.2 億人民幣的收入來自中國的醫療服務。儘管在過去五年中處於虧損狀態並經歷了損失增加，但其每週波動率保持在 6% 的穩定水平，淨負債與股本比率為 32.5%，表現令人滿意。公司的短期資產（29 億人民幣）超過了短期負債（19 億人民幣）和長期負債（8.658 億人民幣）。儘管朱喬納森先生最近辭去了董事會職務，艾迪康的管理團隊仍然經驗豐富，平均任期為 4.2 年，支持未來潛在的戰略舉措。</p>
</div><ul>
<li>Navigate through the intricacies of Adicon Holdings with our comprehensive balance sheet health report here.</li>
<li>Review our growth performance report to gain insights into Adicon Holdings' future.</li>
</ul>
<div class="lb-trans"><ul>
<li>通過我們的綜合資產負債表健康報告，深入瞭解艾迪康控股的複雜性。</li>
<li>查看我們的增長表現報告，以獲取關於艾迪康控股未來的見解。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/4a50de19-77c6-4173-aab9-81d2af195aa5/chart/revenue-and-expenses-breakdown" alt="" original-src="https://images.simplywall.st/company/4a50de19-77c6-4173-aab9-81d2af195aa5/chart/revenue-and-expenses-breakdown"/></p>
<p>SEHK:9860 Revenue &amp; Expenses Breakdown as at Jan 2026</p>
<div class="lb-trans"><p>SEHK:9860 截至 2026 年 1 月的收入與支出明細</p>
</div><h2>Turning Ideas Into Actions</h2>
<div class="lb-trans"><h2>將想法轉化為行動</h2>
</div><ul>
<li>Dive into all 958 of the Asian Penny Stocks we have identified here.</li>
<li>Ready To Venture Into Other Investment Styles? This technology could replace computers: discover the 29 stocks are working to make quantum computing a reality.</li>
</ul>
<div class="lb-trans"><ul>
<li>深入瞭解我們識別的所有 958 只亞洲便士股票。</li>
<li>準備進入其他投資風格嗎？這項技術可能取代計算機：發現 29 只股票正在努力使量子計算成為現實。</li>
</ul>
</div><p><em>This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.</em></p>
<div class="lb-trans"><p><em>本文由 Simply Wall St 撰寫，內容具有一般性。<strong>我們提供基於歷史數據和分析師預測的評論，採用無偏見的方法，我們的文章並不構成財務建議。</strong> 這並不構成買入或賣出任何股票的推薦，也未考慮您的目標或財務狀況。我們的目標是為您提供以基本數據驅動的長期分析。請注意，我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中沒有持倉。</em></p>
</div>

亞洲便士股亮點：立堾集團控股及其他兩個值得關注的選擇